Evaluation and management of psoriatic arthritis: the role of biologic therapy (Q35190112)

7 August 2017

1 reference

title

Evaluation and management of psoriatic arthritis: the role of biologic therapy (English)

1 reference

7 August 2017

1 reference

Eric M Ruderman

1

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 August 2003

1 reference

Journal of the American Academy of Dermatology

7 August 2017

published in

1 reference

7 August 2017

volume

49

1 reference

7 August 2017

issue

2 Suppl

1 reference

7 August 2017

page(s)

S125-32

1 reference

The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence?

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Familial occurrence of psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Natural history of psoriasis in 61 twin pairs

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Psoriatic arthritis. Genetics and HLA antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Reduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated Response

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Tumour necrosis factor alpha is pro-inflammatory in normal human skin and modulates cutaneous adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Characterization of transendothelial chemotaxis of T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

1 reference

7 January 2021

Classification of clinical subsets in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

The prevalence of sacroilitis in psoriatic arthritis: new perspectives from a large, multicenter cohort. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Juvenile psoriatic arthritis--an analysis of 60 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Juvenile psoriatic arthritis and HLA antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Psoriatic arthritis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Psoriasis causes as much disability as other major medical diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Exacerbation of psoriasis by indomethacin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Therapy with cyclosporine in psoriatic arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Sulphasalazine in psoriatic arthritis: a randomized, multicentre, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Interventions for psoriatic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Methotrexate and histologic hepatic abnormalities: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Guidelines for the management of rheumatoid arthritis: 2002 Update

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Renal toxicity associated with disease-modifying antirheumatic drugs used for the treatment of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Treatment of psoriatic arthritis with antitumour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treatment with methotrexate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2803%2901145-9

7 January 2021

10.1016/S0190-9622(03)01145-9

Identifiers

DOI

1 reference

7 August 2017

1 reference